Immunogenicity and Safety of Half-Dose Heterologous mRNA-1273 Booster Vaccination for Adults Primed with the CoronaVac^® and ChAdOx1-S Vaccines for SARS-CoV-2

Coronavirus disease 2019 (COVID-19) has been extensively researched, particularly with regard to COVID-19 vaccines. However, issues with logistics and availability might cause delays in vaccination programs. Thus, the efficacy and safety of half-dose heterologous mRNA should be explored. This was an...

Descripció completa

Dades bibliogràfiques

Autors principals:	Nina Dwi Putri, Aqila Sakina Zhafira, Pratama Wicaksana, Robert Sinto, Gryselda Hanafi, Lowilius Wiyono, Ari Prayitno, Mulya Rahma Karyanti, Murni Luciana Naibaho, Febrina Febrina, Hadyana Sukandar, Vivi Setiawaty, Mursinah Mursinah, Ahmat Rediansya Putra, Heri Wibowo, Julitasari Sundoro, Hindra Irawan Satari, Dwi Oktavia, Pretty Multihartina, Dante Saksono Harbuwono, Sri Rezeki Hadinegoro
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2024-03-01
Col·lecció:	Vaccines
Matèries:	COVID-19 vaccine half-dose mRNA booster safety
Accés en línia:	https://www.mdpi.com/2076-393X/12/4/344
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!